Clinical Trials Directory

Trials / Completed

CompletedNCT03340818

Bone Marrow Concentrate Intradiscal Injection for Chronic Discogenic Low Back Pain

Bone Marrow Concentrate Intradiscal Injection for Chronic Discogenic Low Back Pain: A Double-Blind, Placebo Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
APM Spine and Sports Physicians · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

A double-blind, placebo-controlled study to determine the efficacy of intradiscal injection of bone marrow concentrate on discogenic low back pain.

Detailed description

A randomized, double-blind, placebo-controlled study to determine the efficacy of intradiscal injection of bone marrow concentrate on discogenic low back pain. The treatment will be a single injection of autologous bone marrow concentrate into suspected painful disc(s) based upon either prior discography or combination of imaging and exclusion of other anatomic structural sources of pain. The placebo treatment will be an intramuscular injection of normal saline directly dorsal to the transverse process at each suspected level. Outcomes will be measured using VAS and ODI. The primary outcome will be the percentage of patients in the treatment group vs control group at 6 months post-procedure, categorized as a clinical success defined by at least 50% relief of pain. Secondary outcomes will be comparison of success rates at 3 and 12 months, percentage of patients in the two groups with greater than 30% improvement in ODI at 3, 6 and 12 months, Global perceived index at 3, 6, 12 months. Medication log and adjunctive treatments will be recorded and analyzed.

Conditions

Interventions

TypeNameDescription
OTHERBone Marrow ConcentrateBone marrow concentrate is bone marrow harvested from the iliac crest and minimally processed in a centrifuge. It is then injected into the suspected painful disc (s) using fluoroscopic guidance
OTHERPlaceboInjection of normal saline dorsal to the transverse process after sham bone marrow aspiration

Timeline

Start date
2018-08-01
Primary completion
2024-08-07
Completion
2024-08-07
First posted
2017-11-14
Last updated
2024-08-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03340818. Inclusion in this directory is not an endorsement.